Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
China · Delayed Price · Currency is CNY 26.84
-0.34 (-1.25%)
At close: Feb 13, 2026
SHE:301206 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 91.34 | 104.95 | 55.98 | 163.69 | 535.42 | 232.57 |
Depreciation & Amortization | 66.21 | 66.21 | 59.61 | 38.75 | 25.65 | 16.89 |
Other Amortization | 0.05 | 0.05 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | - | - | - | 0.59 | 0.35 |
Asset Writedown & Restructuring Costs | 0.07 | 0.07 | - | 0.21 | 0.01 | 2.7 |
Loss (Gain) From Sale of Investments | -108.58 | -108.58 | -108.86 | -86.15 | -0.26 | -0.44 |
Provision & Write-off of Bad Debts | 0.64 | 0.64 | 0.05 | -0.24 | 0.36 | -0.06 |
Other Operating Activities | 31.74 | - | 0.15 | 5.18 | 1.22 | 4.59 |
Change in Accounts Receivable | -42.17 | -42.17 | -97.92 | 98.13 | -165.73 | -137.07 |
Change in Inventory | -38.38 | -38.38 | -2.53 | 10.21 | -43.95 | -22.3 |
Change in Accounts Payable | -19.7 | -19.7 | 147.99 | -165.77 | 277.22 | 114.04 |
Operating Cash Flow | 4.48 | -13.65 | 57.31 | 84.26 | 642.08 | 217.37 |
Operating Cash Flow Growth | -89.41% | - | -31.99% | -86.88% | 195.39% | 45.67% |
Capital Expenditures | -165.87 | -141.76 | -122.99 | -242.67 | -434.37 | -151.76 |
Sale of Property, Plant & Equipment | 0.06 | - | - | - | 0.03 | 0.03 |
Sale (Purchase) of Real Estate | - | - | - | -11.47 | - | - |
Investment in Securities | 344.3 | 272.65 | -150.04 | -3,096 | - | - |
Other Investing Activities | 294.46 | 34.78 | -7.05 | 32.9 | -11.58 | 4.25 |
Investing Cash Flow | 472.95 | 165.66 | -280.07 | -3,317 | -445.93 | -147.48 |
Short-Term Debt Issued | - | - | - | - | 1 | - |
Total Debt Issued | - | - | - | - | 1 | - |
Short-Term Debt Repaid | - | - | - | - | -1 | - |
Total Debt Repaid | - | - | - | - | -1 | - |
Issuance of Common Stock | - | - | - | 3,568 | - | - |
Common Dividends Paid | -241.02 | -80.9 | -143.16 | -134.88 | - | -70.81 |
Dividends Paid | -241.02 | -80.9 | -143.16 | -134.88 | - | -70.81 |
Other Financing Activities | -49.98 | -17.6 | - | -14.7 | 5.22 | -10.79 |
Financing Cash Flow | -291 | -98.5 | -143.16 | 3,418 | 5.22 | -81.6 |
Foreign Exchange Rate Adjustments | -0.1 | 2.81 | 1.38 | 24.93 | -1.19 | -4.59 |
Net Cash Flow | 186.34 | 56.32 | -364.54 | 210.57 | 200.18 | -16.31 |
Free Cash Flow | -161.39 | -155.41 | -65.68 | -158.4 | 207.7 | 65.6 |
Free Cash Flow Growth | - | - | - | - | 216.60% | 673.63% |
Free Cash Flow Margin | -23.94% | -21.80% | -13.15% | -23.47% | 12.40% | 8.38% |
Free Cash Flow Per Share | -0.81 | -0.77 | -0.33 | -0.79 | 1.37 | 0.43 |
Cash Interest Paid | - | - | - | - | 0 | - |
Cash Income Tax Paid | - | -56.68 | -51.98 | -40.64 | 2.93 | 2.99 |
Levered Free Cash Flow | 1,346 | -395.91 | -116.43 | -432.86 | 146.47 | 71.22 |
Unlevered Free Cash Flow | 1,346 | -395.91 | -116.43 | -432.86 | 146.47 | 71.22 |
Change in Working Capital | -77 | -77 | 50.38 | -37.17 | 79.1 | -39.23 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.